NTx

Assembly Line

NTx Raises $47.5M in Series B Funding to Advance Next Generation Biomanufacturing

📅 Date:

🔖 Topics: Funding Event

🏢 Organizations: NTx, RA Capital


Nature’s Toolbox, Inc. (NTx), a life sciences company building next generation platforms to manufacture RNA and protein, announced today that it has raised $47.5M in Series B financing. Led by RA Capital Management, the investment will fuel the advancement of the company’s biomanufacturing platforms, NTxscribe® and NTxpress®. Acceleration of these technology foundations will enable distribution of manufacturing capabilities globally, ultimately providing solutions to prepare for future pandemic events, personalized medicine therapy, and increased access to critical vaccines and medicines.

“This financing will help us work toward our mission of delivering innovative biomanufacturing solutions designed to manufacture therapeutics in a more rapid, accessible, and sustainable way. This was also the largest Series B round raised by a New Mexico life sciences company in recent history,” said Jamie Coffin, Ph.D., CEO of NTx. “We are thrilled to have RA Capital Management lead the round. This major commitment and the addition of Peter Kolchinsky, Ph.D. to our Board of Directors will accelerate NTx’s technology development and commercial penetration with leading biopharma, healthcare, and government entities.”

Read more at Business Wire